Src is a novel potential off‐target of RXR agonists, 9‐cis‐UAB30 and Targretin, in human breast cancer cells

Publisher: John Wiley & Sons Inc

E-ISSN: 1098-2744|54|12|1596-1604

ISSN: 0899-1987

Source: Molecular Carcinogenesis, Vol.54, Iss.12, 2015-12, pp. : 1596-1604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract